Target intelligence / Profile preview

Axon guidance receptor tyrosine kinase

Molecular classification
Receptor tyrosine kinase (RTK), Growth factor receptor, Transmembrane receptor, Neurotrophin receptor, Cell surface receptor
01

Overview

Axon guidance receptor tyrosine kinases, notably Trk and RET family receptors, are transmembrane proteins that combine ligand-dependent tyrosine kinase activity and crucial roles in neural development. Upon binding their specific growth factor ligands (such as neurotrophins for Trk, GDNF for RET), these receptors dimerize and activate intracellular signaling cascades, promoting neuronal survival, differentiation, growth cone dynamics, and overall axonal pathfinding. Dysregulation via gene fusions or mutations leads to diverse disease states, particularly a range of malignancies and developmental disorders, making these receptors high-priority therapeutic and diagnostic targets.

Other names
Trk receptorTropomyosin receptor kinaseRET proto-oncogeneNeurotrophin receptor tyrosine kinaseNTRK1 (TrkA gene)Growth factor receptorGDNF receptor (RET)
02

Mechanism of action

Kinase inhibition (competitive ATP binding inhibition); Prevention of signal transduction (blocking phosphorylation cascades); Induction of apoptosis in malignant cells

03

Biological functions

Axon guidanceSignal transductionNeuronal survival and differentiationCell proliferationCell migrationCell cycle regulationApoptosis (programmed cell death)
04

Disease associations

Cancer (e.g., thyroid cancer via Trk and RET fusions, other solid tumors)Neurodegenerative disease (loss of neurotrophic signaling)Developmental disorders (e.g., Hirschsprung's disease with RET mutations)Multiple endocrine neoplasia syndromes (MEN2A, MEN2B)Other (psychiatric and neurological disorders due to altered neurotrophin signaling)
05

Safety considerations

Off-target toxicity (due to RTK expression in non-tumor tissues)Neurotoxicity (particularly with neurotrophin pathway inhibition)CardiotoxicityResistance via secondary mutations
06

Interacting drugs

Larotrectinib

4 more in the full profile.

07

Biomarkers

NTRK gene fusions (Trk receptors)RET gene mutations or fusionsPhosphorylated RTK levels (for pathway activity monitoring)

Beyond the preview

Go deeper on Axon guidance receptor tyrosine kinase.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Axon guidance receptor tyrosine kinase.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call